Bright Minds Biosciences (DRUG) 6-K Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2023

Commission File Number: 001-40997

Bright Minds Biosciences Inc.
(Translation of registrant's name into English)

19 Vestry Street
New York, NY 10013
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F  [ X ]  Form 40-F [  ]

SUBMITTED HEREWITH

Exhibits
99.1	Press Release dated April 10, 2023

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Bright Minds Biosciences Inc.
Date: April 10, 2023	/s/ Ryan Cheung
	Ryan Cheung
	Chief Financial Officer